Literature DB >> 26034381

Reversible sinusoidal obstruction syndrome associated with tacrolimus following liver transplantation.

Tian Shen1, Xiao-Wen Feng1, Lei Geng1, Shu-Sen Zheng1.   

Abstract

Sinusoidal obstruction syndrome (SOS), previously known as hepatic veno-occlusive disease, is a rare disorder in solid organ transplant patients, and is an uncommon complication after liver transplantation. Severe SOS with hepatic failure causes considerable mortality. Tacrolimus has been reported to be an offending agent, which potentially plays a role in the pathophysiological process of SOS. SOS due to tacrolimus has been reported in lung and pancreatic transplantations, but has never been described in a liver transplant recipient. Herein, we present a case of SOS after liver transplantation, which was possibly related to tacrolimus. A 27-year-old man developed typical symptoms of SOS with painful hepatomegaly, ascites and jaundice after liver transplantation, which regressed following withdrawal of tacrolimus. By excluding other possible predisposing factors, we concluded that tacrolimus was the most likely cause of SOS.

Entities:  

Keywords:  Liver transplantation; Predisposing factor; Sinusoidal obstruction syndrome; Tacrolimus; Veno-occlusive disease

Mesh:

Substances:

Year:  2015        PMID: 26034381      PMCID: PMC4445123          DOI: 10.3748/wjg.v21.i20.6422

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  14 in total

1.  "Silent" presentation of veno-occlusive disease after liver transplantation as part of the process of cellular rejection with endothelial predilection.

Authors:  M Sebagh; M Debette; D Samuel; J F Emile; B Falissard; V Cailliez; D Shouval; H Bismuth; M Reynès
Journal:  Hepatology       Date:  1999-11       Impact factor: 17.425

Review 2.  Review article: updates in the pathogenesis and therapy of hepatic sinusoidal obstruction syndrome.

Authors:  A Helmy
Journal:  Aliment Pharmacol Ther       Date:  2006-01-01       Impact factor: 8.171

3.  Hepatic veno-occlusive disease after taking Gynura Rhizome: The value of multidetector computed tomography in diagnosing the disease and evaluating the clinical therapeutic effect.

Authors:  Xing-Wang Wu; Wan-Qin Wang; Bin Liu; Jian-Ming Xu; Yong-Qiang Yu; Shuai Zhang; Yun Shen
Journal:  Hepatol Res       Date:  2011-12-05       Impact factor: 4.288

4.  Significance of isolated hepatic veno-occlusive disease/sinusoidal obstruction syndrome after liver transplantation.

Authors:  Mylène Sebagh; Daniel Azoulay; Bruno Roche; Emir Hoti; Vincent Karam; Elina Teicher; Laurence Bonhomme-Faivre; Faouzi Saliba; Jean-Charles Duclos-Vallée; Didier Samuel
Journal:  Liver Transpl       Date:  2011-07       Impact factor: 5.799

5.  Hepatic veno-occlusive disease due to tacrolimus in a single-lung transplant patient.

Authors:  S Shah; M Budev; H Blazey; K Fairbanks; A Mehta
Journal:  Eur Respir J       Date:  2006-05       Impact factor: 16.671

6.  Veno-occlusive disease/sinusoidal obstruction syndrome associated with potential antibody-mediated rejection after pediatric living donor liver transplantation: a case report.

Authors:  N Yamada; T Urahashi; Y Ihara; Y Sanada; T Wakiya; N Okada; K Mizuta
Journal:  Transplant Proc       Date:  2012-04       Impact factor: 1.066

Review 7.  Successful treatment of severe azathioprine-induced hepatic veno-occlusive disease in a kidney-transplanted patient with transjugular intrahepatic portosystemic shunt.

Authors:  D Azoulay; D Castaing; A Lemoine; D Samuel; P Majno; M Reynes; B Charpentier; H Bismuth
Journal:  Clin Nephrol       Date:  1998-08       Impact factor: 0.975

8.  Veno occlusive disease: update on clinical management.

Authors:  M Senzolo; G Germani; E Cholongitas; P Burra; A-K Burroughs
Journal:  World J Gastroenterol       Date:  2007-08-07       Impact factor: 5.742

9.  BCSH/BSBMT guideline: diagnosis and management of veno-occlusive disease (sinusoidal obstruction syndrome) following haematopoietic stem cell transplantation.

Authors:  Fiona L Dignan; Robert F Wynn; Nedim Hadzic; John Karani; Alberto Quaglia; Antonio Pagliuca; Paul Veys; Michael N Potter
Journal:  Br J Haematol       Date:  2013-09-17       Impact factor: 6.998

10.  [Veno-occlusive disease after liver transplantation. Association of acute cellular rejection and toxicity of azathioprine].

Authors:  F Mion; P Cloix; O Boillot; D Gille; R Bouvier; P Paliard; F Berger
Journal:  Gastroenterol Clin Biol       Date:  1993
View more
  6 in total

1.  Inferior vena cava stenosis-induced sinusoidal obstructive syndrome after living donor liver transplantation.

Authors:  Batsaikhan Bat-Erdene; Sergelen Orgoi; Erdene Sandag; Ulzii-Orshikh Namkhai; Bat-Ireedui Badarch; Batsaikhan Batsuuri
Journal:  Korean J Hepatobiliary Pancreat Surg       Date:  2016-08-29

2.  Diagnostic performance of Contrast-enhanced CT in Pyrrolizidine Alkaloids-induced Hepatic Sinusoidal Obstructive Syndrome.

Authors:  Xuefeng Kan; Jin Ye; Xinxin Rong; Zhiwen Lu; Xin Li; Yong Wang; Ling Yang; Keshu Xu; Yuhu Song; Xiaohua Hou
Journal:  Sci Rep       Date:  2016-11-29       Impact factor: 4.379

Review 3.  Defibrotide in the treatment of hepatic veno-occlusive disease.

Authors:  Alessandro Fulgenzi; Maria Elena Ferrero
Journal:  Hepat Med       Date:  2016-10-31

Review 4.  Pyrrolizidine alkaloids-induced hepatic sinusoidal obstruction syndrome: Pathogenesis, clinical manifestations, diagnosis, treatment, and outcomes.

Authors:  Xiao-Qian Yang; Jin Ye; Xin Li; Qian Li; Yu-Hu Song
Journal:  World J Gastroenterol       Date:  2019-07-28       Impact factor: 5.742

Review 5.  Management of hepatic vein occlusive disease after liver transplantation: A case report with literature review.

Authors:  Yuchen Hou; Nga Lei Tam; Zhicheng Xue; Xuzhi Zhang; Bing Liao; Jie Yang; Shunjun Fu; Yi Ma; Linwei Wu; Xiaoshun He
Journal:  Medicine (Baltimore)       Date:  2018-06       Impact factor: 1.889

6.  Successful defibrotide treatment of a patient with veno-occlusive disease after living-donor liver transplantation: A case report.

Authors:  Tae Beom Lee; Kwangho Yang; Hyo Jung Ko; Jae Ryong Shim; Byung Hyun Choi; Jung Hee Lee; Je Ho Ryu
Journal:  Medicine (Baltimore)       Date:  2021-06-25       Impact factor: 1.889

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.